These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 17899079)

  • 41. Another beneficial effect of rituximab on refractory and relapsing thrombotic thrombocytopenic purpura: the role of interleukin-12 suppression?
    Park SJ; Shin JI
    Crit Care Med; 2012 Apr; 40(4):1391. PubMed ID: 22425862
    [No Abstract]   [Full Text] [Related]  

  • 42. Thrombotic thrombocytopenic purpura. II. Principles of therapy and guidelines for management.
    Sills RH
    Am J Pediatr Hematol Oncol; 1984; 6(4):431-9. PubMed ID: 6398631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombotic thrombocytopenic purpura: Going with the evidence.
    Zimrin AB; Hess JR
    Crit Care Med; 2006 Aug; 34(8):2247-8. PubMed ID: 16883196
    [No Abstract]   [Full Text] [Related]  

  • 44. [Rituximab as effective therapy in very severe thrombotic thrombocytopenic purpura (TTP)].
    Illner N; Wolf G
    Dtsch Med Wochenschr; 2010 May; 135(3):71-4. PubMed ID: 20077379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Efficacy of plasma therapy in thrombotic thrombocytopenic purpura].
    Koyama T; Koura Y; Uejima R; Tanaka H; Suehiro Y
    Rinsho Ketsueki; 1987 Oct; 28(10):1860-3. PubMed ID: 3452650
    [No Abstract]   [Full Text] [Related]  

  • 46. Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpura.
    Benetatos L; Vassou A; Bourantas KL
    Clin Lab Haematol; 2006 Aug; 28(4):288-9. PubMed ID: 16898975
    [No Abstract]   [Full Text] [Related]  

  • 47. Thrombotic thrombocytopenic purpura with severe neurological impairment: remission after Rituximab.
    Magalini F; Stella A; Basaglia M; Vescovini R; Sassi M; Maria Lombardi A; Sansoni P
    Transfus Med; 2011 Apr; 21(2):140-3. PubMed ID: 21118315
    [No Abstract]   [Full Text] [Related]  

  • 48. Refractory post-pancreatitis thrombotic thrombocytopenic purpura: response to rituximab.
    Ruiz J; Koduri PR; Valdivieso M; Shah PC
    Ann Hematol; 2005 Apr; 84(4):267-8. PubMed ID: 15538566
    [No Abstract]   [Full Text] [Related]  

  • 49. Membrane plasma exchange for the treatment of thrombotic thrombocytopenic purpura.
    Marn Pernat A; Buturović-Ponikvar J; Kovac J; Knap B; Premru V; Benedik M; Varl J; Skofic N; Gubensek J; Kersnic B; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):318-21. PubMed ID: 19695067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Thrombotic thrombocytopenic purpura (Moschcowitz syndrome) in a patient with EPH gestosis. The pathophysiologic principle of HELLP syndrome? On the question of the identity of the HELLP syndrome with thrombotic thrombocytopenic purpura].
    Staiger HJ; Fettig O; Theml H
    Geburtshilfe Frauenheilkd; 1989 Jun; 49(6):597-600. PubMed ID: 2663622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Splenectomy during partial remission in thrombotic thrombocytopenic purpura with prolonged plasma exchange dependency.
    Mant MJ; Turner AR; Bruce D; Ritchie C; Larratt LM
    Am J Hematol; 1999 Sep; 62(1):56-7. PubMed ID: 10467278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus.
    Limal N; Cacoub P; Sène D; Guichard I; Piette JC
    Lupus; 2008 Jan; 17(1):69-71. PubMed ID: 18089688
    [No Abstract]   [Full Text] [Related]  

  • 53. Unsuccessful treatment of resistant thrombotic thrombocytopenic purpura with prostacyclin.
    Salvi F; Baraldi A; Allione B; Santi R; Inverardi D; Levis A
    Haematologica; 2000 Dec; 85(12):1329-30. PubMed ID: 11114144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Thrombotic thrombocytopenic purpura successfully treated with plasma exchange].
    Smolewski P; Chojnowski K; Filutowicz J; Krykowski E; Robak T; Dubla-Berner M; Pruszczyński W
    Przegl Lek; 1996; 53(8):636-8. PubMed ID: 8999469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new treatment for TTP?
    Fakhouri F; Deroure B; Hummel A
    Nephrol Dial Transplant; 2006 Mar; 21(3):577-9. PubMed ID: 16401622
    [No Abstract]   [Full Text] [Related]  

  • 56. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.
    Page EE; Kremer Hovinga JA; Terrell DR; Vesely SK; George JN
    Blood; 2016 Jun; 127(24):3092-4. PubMed ID: 27060171
    [No Abstract]   [Full Text] [Related]  

  • 57. Daratumumab for refractory immune-mediated thrombotic thrombocytopenic purpura.
    Aggarwal A; White D; Pavord S; Thomas W; Desborough MJR
    Br J Haematol; 2023 Jul; 202(2):429-433. PubMed ID: 37183296
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful treatment with cyclosporine of thrombotic thrombocytopenic purpura refractory to corticosteroids and plasma exchange.
    Honda K; Hidaka S; Kobayashi S
    Ther Apher Dial; 2011 Apr; 15(2):215-7. PubMed ID: 21426520
    [No Abstract]   [Full Text] [Related]  

  • 59. [Thrombotic thrombocytopenic purpura treated with plasma-exchange, exchange transfusion and plasma infusion: description of a case].
    Donada C; Orazi BM; Santarossa L; De Angelis V; Conti F
    Riv Emoter Immunoematol; 1986; 33(1):69-74. PubMed ID: 3764310
    [No Abstract]   [Full Text] [Related]  

  • 60. Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: report of four cases.
    Pequeño-Luévano M; Villarreal-Martínez L; Jaime-Pérez JC; Gómez-de-León A; Cantú-Rodríguez OG; González-Llano O; Gómez-Almaguer D
    Hematology; 2013 Jul; 18(4):233-6. PubMed ID: 23432850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.